Thursday, July 7, 2022
Market-Reporter
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
Market-Reporter
No Result
View All Result
Home Stocks

Vaccine stocks slide after Novavax shot proves highly effective

MtR by MtR
June 14, 2021
in Stocks
0


The world’s top makers of COVID-19 vaccines dropped after tests of Novavax Inc.’s shots showed they were 90 per cent effective at preventing symptoms.

Stocks tied to inoculations already cleared for emergency use fell in Monday trading, led by Moderna Inc closed down 5.2 per cent after dropping 9.5 per cent intraday. Pfizer Inc. fell 1.3 per cent and the drugmaker’s German partner BioNTech SE dropped 7.5 per cent. Consumer giant Johnson & Johnson reversed earlier losses to close up 0.3 per cent, slightly more than the S&P 500 index as the broader market closed at record highs.

Novavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5 per cent gain on Monday to close down about 1 per cent. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.

Embedded Image

But with Novavax up 86 per cent so far this year and after a more than 2,700 per cent leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalysts, only to give back gains even after a positive update.





Source link

Related articles

Stocks in the doldrums as euro founders on recession fears

July 7, 2022

Why Snowflake, Okta, and Atlassian Stocks All Beat the Market In June

July 6, 2022

Related Posts

Stocks in the doldrums as euro founders on recession fears

by MtR
July 7, 2022
0

SINGAPORE - The euro huddled at a two-decade low on Thursday and oil nursed losses as investors fretted about a...

Why Snowflake, Okta, and Atlassian Stocks All Beat the Market In June

by MtR
July 6, 2022
0

What happened The first half of 2022 was one for the record books, with both the S&P 500 and Nasdaq...

Bank stocks are super cheap — even with the risk of recession

by MtR
July 6, 2022
0

Big banks will kick off earnings season next week, with JPMorgan Chase first out of the gate before the stock...

Stocks Swing Ahead of Fed Meeting Minutes

by MtR
July 6, 2022
0

US stocks edged higher Wednesday as investors prepared to sift through minutes from the Federal Reserve 's most recent policy...

European stocks bounce back after strong German industrial figures

by MtR
July 6, 2022
0

European stocks rallied on Wednesday, pushed up by a sharp rise in the shares of Just Eat Takeaway after Amazon...

Load More
  • Trending
  • Comments
  • Latest

Bank of England tells ministers to intervene on digital currency ‘programming’

June 21, 2021

Tips for checking smoke alarms during daylight saving time

March 12, 2022

GLOBAL MARKETS-U.S. stocks follow Europe up; Treasury yields rise, dollar firm

July 9, 2021
Fed tapering and emerging markets

Fed tapering and emerging markets

June 7, 2021
African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

0
Maxum Foods releases Global Dairy Commodity Update for June

Maxum Foods releases Global Dairy Commodity Update for June

0
Letter: Perpetual bonds can help states fight hunger

Letter: Perpetual bonds can help states fight hunger

0
United Kingdom ETFs Are Riding the Re-Opening Momentum

United Kingdom ETFs Are Riding the Re-Opening Momentum

0

Stocks in the doldrums as euro founders on recession fears

July 7, 2022

FMA Proposes Guidance for Advising on IPOs, Listed Equity

July 7, 2022

Defendants Secure Motion to Dismiss Victories in Three Post-Hughes Decisions | Proskauer – Employee Benefits & Executive Compensation Blog

July 7, 2022

Some Could Turn to Tech-Heavy Growth ETFs in a Recession

July 7, 2022

Recent News

Stocks in the doldrums as euro founders on recession fears

July 7, 2022

FMA Proposes Guidance for Advising on IPOs, Listed Equity

July 7, 2022

Defendants Secure Motion to Dismiss Victories in Three Post-Hughes Decisions | Proskauer – Employee Benefits & Executive Compensation Blog

July 7, 2022

Categories

  • Asia
  • Bonds
  • Canada
  • Commodities
  • Cryptocurrencies
  • Currencies
  • Emerging Markets
  • ETFs
  • Europe & Middle East
  • IPOs
  • Latin America
  • Mutual Funds
  • Personal Finance
  • Real Estate
  • Retirement
  • Spending & Saving
  • Stocks
  • U.S. Markets
  • Privacy & Policy
  • About Us
  • Contact Us
  • Advertise with us

© 2021 Copyright Market-Reporter

No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate

© 2021 Copyright Market-Reporter